[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$5793m
Breaking news: A major development has just been announced, sending shockwaves through the community and causing a surge in social media activity. Experts are closely monitoring the situation for immediate impacts.
About $5793m
This topic refers to a specific digital asset or cryptocurrency.
Insights #
- $5793m engagements hit 3839 which is XXX% higher than it's daily average.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Month: XXXXXX +5,727%
6 Months: XXXXXX -XX%
1 Year: XXXXXX +7,498%
1-Year High: XXXXXX on 2025-04-18
1-Year Low: X on 2025-01-18
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X -XX%
6 Months: XX -XX%
1 Year: XX +583%
1-Year High: XX on 2025-04-20
1-Year Low: X on 2024-11-27
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $5793m in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X -XX%
6 Months: XX +11%
1 Year: XX +280%
1-Year High: X on 2025-04-19
1-Year Low: X on 2024-11-27
Top assets mentioned In the posts about $5793m in the last XX hours
Hims & Hers Health, Inc. (HIMS) Hims & Hers Health, Inc. (HIMS)
Top topics mentioned In the posts about $5793m in the last XX hours
hims hers, stocks consumer defensive, $hims, $600m, $16m, $2335b, $2355b, outlook
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$HIMS Hims & Hers Health Q3 2025 Earnings Overview Revenue: $600M vs. $579.3M est Strong beat driven by continued subscriber growth and expanding telehealth offerings. Net Income: $16M Profitability sustained as the platform scales. EPS: $XXXX Ahead of expectations supported by operating leverage and disciplined cost structure. FY Revenue Outlook: $2.335B$2.355B Confident full-year guide reflecting durable demand in digital health. FY Adjusted EBITDA Outlook: $307M$317M Continued improvement in operating efficiency. Platform Expansion: Actively working to offer Wegovy injections and Novo"
X Link @WOLF_Financial 2025-11-03T21:07Z 441K followers, 14.9K engagements